Our restructuring team assisted on the Luxembourg aspects in the course of US Chapter 11 proceedings related to Endo International plc.

Under the reorganisation plan, a substantial part of the company's ownership was transferred over to its lender group. The entire restructuring and settlements relating to thousands of opioids lawsuits were approved by the US Bankruptcy Court.

The Endo group is a specialty pharmaceutical group developing and delivering life-enhancing therapies and treatments that include high-value branded pharmaceutical products, generic pharmaceutical products and quality products to patients around the world in competitive and emerging markets.